| scholarly article | Q13442814 |
| P2093 | author name string | Jordan SC | |
| Young S | |||
| Czer LS | |||
| Toyoda M | |||
| Trento A | |||
| Galfayan K | |||
| Freimark D | |||
| Fredrich R | |||
| Galera O | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 385-391 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation | |
| P478 | volume | 67 |
| Q44681568 | Acute rejection and graft survival in renal transplanted patients with viral diseases. |
| Q47924867 | Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome |
| Q37676032 | Advances in diagnosing and managing antibody-mediated rejection |
| Q43063894 | Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascades |
| Q27011330 | Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis |
| Q34241121 | Chronic rejection |
| Q35937515 | Clinical significance of anti-endothelial cell antibody in renal transplant recipients |
| Q33242978 | Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy |
| Q21195897 | Cytomegalovirus-induced immunopathology and its clinical consequences |
| Q82082999 | De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection |
| Q34991698 | Endothelial injury: cause and effect of alloimmune inflammation. |
| Q87015465 | Existence of circulating anti-endothelial cell antibodies after heart transplantation is associated with post-transplant acute allograft rejection |
| Q30920620 | High diversity of non-human leukocyte antigens in transplant-associated coronary artery disease1 |
| Q47789001 | Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies |
| Q36202286 | Human leukocyte antigen antibodies for monitoring transplant patients |
| Q38440953 | Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis |
| Q46126109 | Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. |
| Q92033719 | Impact of pretransplant antibodies on outcomes after heart transplantation |
| Q36007256 | Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians |
| Q24629268 | Mechanisms involved in antibody- and complement-mediated allograft rejection |
| Q38123310 | Moving beyond HLA: a review of nHLA antibodies in organ transplantation |
| Q37384670 | Myocardial Biopsy In "Idiopathic» Atrial Fibrillation And Other Arrhythmias: Nosological Diagnosis, Clinical And Morphological Parallels, And Treatment. |
| Q34259047 | Non-MHC antigenic targets of the humoral immune response in transplantation |
| Q104748205 | Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection |
| Q35574072 | Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching |
| Q39800052 | Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection |
| Q53212434 | Quilty in biopsy is associated with poor prognosis after heart transplantation. |
| Q37313051 | Report from a consensus conference on antibody-mediated rejection in heart transplantation |
| Q44022859 | Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin |
| Q30317554 | Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes |
| Q77369767 | Serum antibody activity to glomerular endothelial cells is a useful indication for renal allograft rejection |
| Q44863799 | Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management |
| Q44237297 | The clinical significance of antibody to vascular endothelial cells after renal transplantation |
| Q34567289 | The endothelium in clinical cardiac transplantation |
| Q33911449 | The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection |
| Q83179025 | [Current status of heart transplantation in Spain] |
Search more.